Loading clinical trials...

Outcomes of Mitral Valve Surgery in Patients Affected by Rheumatic Heart Disease | Clinical Trials | Clareo Health

UNKNOWNNCT04780607

Outcomes of Mitral Valve Surgery in Patients Affected by Rheumatic Heart Disease

rheumatic heart disease remains the majority valvular disease in low and middle income countries, which mostly affected mitral valve, surgical treatment is the most effective strategy to improve the o...

Lead sponsor: Beijing Anzhen Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

xu meng, MD

CONTACT

[email protected]

jintao fu, MD, postdoctor

CONTACT

[email protected]

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment4,000

Start dateJan 2011

Last updatedMar 3, 2021

Locations shown

Beijing Anzhen Hospital

Beijing, Beijing Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 3, 2021Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions